Company Filing History:
1 out of 3 
1 out of 832,843 Years Active: 1997-2001
Title: The Innovative Contributions of Caroline M Myss
Introduction
Caroline M Myss is a notable inventor based in Melrose Park, IL (US). She has made significant contributions to the field of medical technology, particularly in the areas of neurotensin and dehydroepiandrosterone (DHEA). With a total of 2 patents, her work has the potential to impact health and wellness positively.
Latest Patents
One of her latest patents focuses on "Electrical stimulation to increase neurotensin levels." This invention addresses the need for enhancing neurotensin, an endogenous tridecapeptide known for its anti-diabetic, anti-inflammatory, anti-psychotic, neuroleptic, and analgesic properties. The method provides a way to increase endogenous neurotensin levels through electrical stimulation, thereby avoiding the side effects associated with exogenous administration.
Another significant patent is the "Method for enhancement of dehydroepiandrosterone." This method aims to elevate serum DHEA levels in humans, which can improve the host's response to infections and enhance resistance to pathogenic organisms. The serum concentration of DHEA is increased through topically applied preparations containing progesterone, using electronic stimulators on specific acupuncture points, or a combination of both methods.
Career Highlights
Throughout her career, Caroline has worked with various companies, including Biogenics II, LLC. Her innovative approaches have garnered attention in the medical community, showcasing her dedication to advancing health technologies.
Collaborations
Caroline has collaborated with notable individuals such as C Norman Shealy and Saul Liss. These partnerships have contributed to her research and development efforts, further enhancing her inventions' impact.
Conclusion
Caroline M Myss is a pioneering inventor whose work in electrical stimulation and hormone enhancement has the potential to revolutionize medical treatments. Her contributions reflect a commitment to improving health outcomes through innovative technology.